Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 161
Infectious Diseases Drugs 123
Genomics 100
Liver and Kidney Disorders Drugs 68
Immune Disorders Drugs 61
Pharmaceuticals 52
Drug Discovery 48
Cardiovascular Drugs 44
Biopharmaceuticals 42
Biotechnology 41
Leukemia Drugs 37
HIV/AIDS Drugs 37
Lymphoma Drugs 29
Allergy and Immunology 28
Clinical Trials 28
Musculoskeletal Disorders Drugs 27
Enzymes 26
Respiratory Drugs 25
Oncology 22
Pulmonary Medicine 20
Central Nervous System Drugs 20
Drug Delivery 19
Infusions and Injectables 17
Pharmaceutical Manufacturing 17
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 12
Healthcare Services 10
Diagnostics 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Hematology 9
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Drugs by Therapeutic Area 6
Lung Cancer Drugs 6
Hepatology 5
Women's Health 5
Colon Cancer Drugs 5
Analgesics 5
Nanomedicine 5
Company Reports 4
Cervical Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Liver Cancer Drugs 3
Generic Drugs 3
Bladder Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Needles and Syringes 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
E-Healthcare 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

1,018 Results (Page 42 of 51)
- Relevance
  Sort by

Neoantigen Targeted Therapies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

 Report
May 2026
180 Pages
Global

From

€4137EUR$4,500USD£3,526GBP

Antibody Drug Conjugates Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology, Application, Target, Distribution Channel, and Geography

 Report
December 2024
286 Pages
Global

From

€4091EUR$4,450USD£3,486GBP

Large Molecule Injectable Drugs Market 2024-2028

 Report
July 2024
166 Pages
Global

From

€2298EUR$2,500USD£1,959GBP

Waldenstrom Macroglobulinemia Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
104 Pages
Global

From

€3500EUR$4,079USD£3,087GBP

Hodgkin Lymphoma Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
99 Pages
Global

From

€3500EUR$4,079USD£3,087GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

PD-1 and PDL1 Inhibitors/ Immune Checkpoint Inhibitors Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

Targeted Therapy Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

Germ Cell Tumor Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

Appendiceal Cancer Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

TNF Alpha Inhibitors Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

Checkpoint Inhibitors Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

Antibody Drug Conjugates Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

Drugs for Immunotherapy Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

Bi-Specific MAbS Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

CAR-T Therapy Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

Gastric Cancer Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

Penile Cancer Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

Metastatic Cancer Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

DNA Repair Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

 Report
May 2026
185 Pages
Global

From

€4137EUR$4,500USD£3,526GBP

Solid Tumor Cancer Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,518GBP

1,018 Results (Page 42 of 51)
- 1
- 40
- 41
- 42
- 43
- 44

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.